Immune response and liver transplantation
✍ Scribed by Michiel C. Warlé; Hugo W. Tilanus; Herold J. Metselaar
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 41 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20540
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Among solid organ transplant (SOT) recipients, donor-seropositive/recipient-seronegative (Dϩ/RϪ) cytomegalovirus (CMV) status is associated with the highest risk of ganciclovir-resistant CMV disease, which has been reported for patients receiving oral ganciclovir but not valganciclovir prophylaxis.
Recurrent HCV infection after liver transplantation is universal and sustained clearance of HCV-RNA rarely occurs. The aim of this study was to characterize cellmediated immunity and cytokine production in HCVinfected patients after liver transplant. The study included 6 pretransplantation patients
## Abstract Infection of the liver by the human cytomegalovirus (HCMV) frequently occurs after orthotopic liver transplantation (OLT). However, the role of viral replication and the inflammatory reaction in the development of HCMV‐associated liver dysfunction is unclear. To address this question in
Liver transplantation (LTx) is an established and effective treatment for children with end-stage and metabolic liver disease. Improved surgical techniques and immunosuppressive regimens have led to enhanced short-term and long-term survival rates, which now approach or exceed 90%. Consequently, mor
A 55-year-old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune-mediated hepatitis.